Maham Rais

Maham Rais, Ph.D. is a Scientist I in Translational Immuno-Oncology at ImmunityBio, Inc., since July 2023, focusing on IND-enabling studies to evaluate vaccine efficacy against cancer. Prior to this role, Maham served as a Postdoctoral Research Fellow at Seattle Children's from June 2021 to April 2023, conducting research on vaccine development for infectious diseases under the supervision of Rhea Coler. Maham earned a Ph.D. in Biomedical Sciences from UC Riverside, where the dissertation explored the mechanisms of Fragile X Syndrome. Early career experiences include clinical research work and contributions to various studies in immunology and infectious disease, resulting in multiple publications. Maham holds a Bachelor of Science degree in Cell/Cellular and Molecular Biology from Howard University.